Ajanta Pharma (NSE:AJANTPHARM) Total Current Liabilities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJANTPHARM Ajanta Pharma Ltd NSE:AJANTPHARM
95 GF Score
Price ₹3,481.70
GF Value ₹3,348.50
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ajanta Pharma Total Current Liabilities?

Ajanta Pharma NSE:AJANTPHARM -0.66% 95 Total Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AJANTPHARM with a GF Score™ of 95/100 and a GF Value™ of ₹3,348.50 (Fairly Valued). The stock has 6 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Ajanta Pharma's total current liabilities for the quarter that ended in Jun. 2026 was ₹0

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Ajanta Pharma Total Current Liabilities Related Terms

Ajanta Pharma Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ajanta Pharma's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma Total Current Liabilities Chart

Ajanta Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,473.90 11,392.80 8,952.50 9,961.00 14,157.50

Ajanta Pharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 11,598.10 0.00 14,157.50 0.00
NSE:AJANTPHARM
95GF Score
Ajanta Pharma Ltd NSE:AJANTPHARM
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ajanta Pharma Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Ajanta Pharma's Total Current Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=6896.3+2207.5
+Other Current Liabilities+Current Deferred Liabilities
=5053.7+0
=14,158

Ajanta Pharma's Total Current Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of ₹0 Mil mean?
Ajanta Pharma (NSE:AJANTPHARM) has a Total Current Liabilities of ₹0 Mil as of Jun. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Ajanta Pharma and its competitors.
Is Ajanta Pharma's Total Current Liabilities too high?
Ajanta Pharma's current Total Current Liabilities is ₹0 Mil. Overall, Ajanta Pharma has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ajanta Pharma's Total Current Liabilities compare to ZTS?
Ajanta Pharma's Total Current Liabilities of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Drug Manufacturers company?
A good Total Current Liabilities depends on the Drug Manufacturers industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Ajanta Pharma and its competitors. Ajanta Pharma's current Total Current Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ajanta Pharma stock overvalued right now?
Based on GuruFocus' analysis, Ajanta Pharma (NSE:AJANTPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹3,348.50, compared to a current price of ₹3,481.70 — trading 4% above its estimated fair value. The current Total Current Liabilities is ₹0 Mil. Ajanta Pharma's overall GF Score™ is 95/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Ajanta Pharma (NSE:AJANTPHARM), the current Total Current Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ajanta Pharma (NSE:AJANTPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Ajanta Pharma stock appears to be overvalued. The current stock price of ₹3,481.70 is trading 4% above its estimated GF Value™ of ₹3,348.50. GuruFocus considers Ajanta Pharma to be Fairly Valued.

Key valuation signals for NSE:AJANTPHARM:

  • Total Current Liabilities: ₹0 Mil
  • GF Value™: ₹3,348.50 vs. price of ₹3,481.70 (4% above fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the NSE:AJANTPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajanta Pharma Business Description

Other Exchanges 532331:India
Address M Vasanji Road, Ajanta Tower, 54-A, Chakala, Andheri East, Mumbai, MH, IND, 400 093
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
95GF Score

Get the complete analysis for NSE:AJANTPHARM

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,481.70
Price
₹3,348.50
GF Value